Botensilimab and balstilimab combinations deliver unprecedented tumor responses across multiple cancer types, fueling optimism for harder-to-treat colorectal, breast, …
Botensilimab and balstilimab combinations deliver unprecedented tumor responses across multiple cancer types, fueling optimism for harder-to-treat colorectal, breast, …
In a world-first, an infant with a fatal genetic disorder receives a custom, in vivo CRISPR therapy, showcasing …
Breakthroughs in personalized therapies and AI-driven tools are reshaping how cancer is diagnosed and treated, promising better outcomes …
New research unveiled at the American Association for Cancer Research meeting points to promising treatments for head and …
Phase 2 study for Caliway’s CBL-514 highlights significant progress for Dercum’s disease, a rare and painful condition with …
New trial presents and preclinical readouts set to shape the oncology landscape
Phase III ASCENT-04/KEYNOTE-D19 trial reveals meaningful PFS improvement with a novel antibody-drug conjugate/immunotherapy combo
Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
FDA greenlights two major therapies offering new hope for patients with IgA nephropathy and giant cell arteritis
Zydus’ experimental therapy demonstrates significant improvements in liver function and patient outcomes, signaling new hope in a disease …
